Johnson & Johnson Portfolio Stock Holdings
According to the SEC 13F filed on October 26, 2026, Johnson & Johnson disclosed 15 stock positions valued at approximately $761.69M as of quarter-end September 30, 2026. The largest holdings include PROTAGONIST THERAPEUTICS INC, NANOBIOTIX, and MEIRAGTX HLDGS PLC.
- Report Period
- September 30, 2026
- No. of Stocks
- 15
- Portfolio Value
- $761.69M
Holdings by Sector
Johnson & Johnson Portfolio Holdings in Q3 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS INC | PTGX | Healthcare | 45.30% | 2,449,183 | - | - | $345,065,393 |
| NANOBIOTIX | NBTX | Healthcare | 23.01% | 5,623,816 | - | - | $175,238,107 |
| MEIRAGTX HLDGS PLC | MGTX | Healthcare | 9.59% | 6,641,064 | - | - | $73,051,704 |
| RAPPORT THERAPEUTICS INC | RAPP | Healthcare | 7.87% | 1,784,517 | - | - | $59,959,771 |
| CONTINEUM THERAPEUTICS INC | CTNM | Healthcare | 3.49% | 1,979,173 | - | - | $26,560,502 |
| CEREBRAS SYSTEMS INC | CBRS | Technology | 3.00% | 128,649 | +75,063 | +140.08% | $22,854,495 |
| XENCOR INC | XNCR | Healthcare | 2.45% | 748,062 | - | - | $18,664,147 |
| LEGEND BIOTECH CORP | LEGN | Healthcare | 2.13% | 814,586 | - | - | $16,202,116 |
| FATE THERAPEUTICS INC | FATE | Healthcare | 1.05% | 3,379,064 | - | - | $8,008,382 |
| CVRX INC | CVRX | Healthcare | 0.92% | 4,024,861 | - | - | $7,043,507 |
| PROCEPT BIOROBOTICS CORP | PRCT | Healthcare | 0.86% | 357,939 | - | - | $6,521,649 |
| NEUMORA THERAPEUTICS INC. | NMRA | Healthcare | 0.14% | 1,849,445 | - | - | $1,102,639 |
| VOR BIOPHARMA INC | VOR | Healthcare | 0.13% | 53,732 | - | - | $1,025,207 |
| STANDARD BIOTOOLS INC | LAB | Healthcare | 0.03% | 311,967 | - | - | $231,043 |
| ADICET BIO INC | ACET | Healthcare | 0.02% | 22,779 | - | - | $162,642 |
Showing 15 of 15 holdings in the latest reporting period.